Avicanna Inc. announced the appointment of Eileen McCormack to, and the resignation of Setu Purohit from, its board of directors effective immediately. Eileen McCormack is an experienced senior marketing executive with more than 30 years of international
experience in the bio-pharmaceutical industry. Ms. McCormack retired from AstraZeneca US where she
led commercial and cross-functional teams responsible for launch planning and business development in
the US market. Ms. McCormack has experience in bio-pharmaceutical product development, portfolio
strategy in complex regulated environments and brings significant multi-market and international
commercial experience. Ms. McCormack gives back to her community by having served on a number of
national and Toronto-based non-for-profit boards over the last 10 years.